These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis. Ai P, Zhang X, Xie Z, Liu G, Liu X, Pan S, Wang H. Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630 [Abstract] [Full Text] [Related]
4. Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis. Peng Y, Liu B, Pei S, Zheng D, Wang Z, Ji T, Pan S, Shen HY, Wang H. Front Immunol; 2019 Feb; 10():905. PubMed ID: 31214158 [Abstract] [Full Text] [Related]
5. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis. Byun JI, Lee ST, Moon J, Jung KH, Sunwoo JS, Lim JA, Kim TJ, Shin YW, Lee KJ, Jun JS, Lee HS, Lee WJ, Kim YS, Kim S, Jeon D, Park KI, Jung KY, Kim M, Chu K, Lee SK. J Neuroimmunol; 2016 Aug 15; 297():141-7. PubMed ID: 27397087 [Abstract] [Full Text] [Related]
7. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation. Li Y, Yang K, Zhang F, Wang J, Shen H, Liu M, Guo J, Wang J. Front Immunol; 2022 Aug 15; 13():971659. PubMed ID: 36389787 [Abstract] [Full Text] [Related]
9. Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis. Peng Y, Zheng D, Zhang X, Pan S, Ji T, Zhang J, Shen HY, Wang HH. Front Immunol; 2019 Aug 15; 10():103. PubMed ID: 30792710 [Abstract] [Full Text] [Related]
11. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid. Liba Z, Kayserova J, Elisak M, Marusic P, Nohejlova H, Hanzalova J, Komarek V, Sediva A. J Neuroinflammation; 2016 Mar 03; 13(1):55. PubMed ID: 26941012 [Abstract] [Full Text] [Related]
12. Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis. Shu Y, Chen C, Chen Y, Xu Y, Chang Y, Li R, Sun X, Peng L, Lu Z, Qiu W. Eur J Neurol; 2018 Jan 03; 25(1):178-184. PubMed ID: 29053906 [Abstract] [Full Text] [Related]
13. Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections. Zatta M, Di Bella S, Bottazzi B, Rossi F, D'Agaro P, Segat L, Fabbiani M, Mantovani A, Luzzati R. Eur J Clin Microbiol Infect Dis; 2020 Apr 03; 39(4):665-670. PubMed ID: 31813079 [Abstract] [Full Text] [Related]
19. Th17 cells were recruited and accumulated in the cerebrospinal fluid and correlated with the poor prognosis of anti-NMDAR encephalitis. Zeng C, Chen L, Chen B, Cai Y, Li P, Yan L, Zeng D. Acta Biochim Biophys Sin (Shanghai); 2018 Dec 01; 50(12):1266-1273. PubMed ID: 30418472 [Abstract] [Full Text] [Related]
20. Lipid Metabolism in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Shu Y, Qin B, Xu Y, Sun X, Chen Z, Wang J, Peng L, Qiu W, Lu Z, Wu A. Neuroimmunomodulation; 2017 Dec 01; 24(4-5):256-263. PubMed ID: 29393234 [Abstract] [Full Text] [Related] Page: [Next] [New Search]